Role of “Ischemia Modified Albumin” (IMA) in acute coronary syndromes
Background: Diagnosis of acute coronary syndrome (ACS) is important, due to the associated very high mortality. Failure to diagnose ACS is a problem both for the patients and the clinicians. Ischemia modified albumin (IMA) has already been licensed by the US Food and Drug Administration for the diag...
Main Authors: | C. Bhakthavatsala Reddy, Cijo Cyriac, Hrishikesh B. Desle |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-11-01
|
Series: | Indian Heart Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483214007421 |
Similar Items
-
Value of ischemia modified albumin (IMA) for diagnosis of acute coronary syndrome (ACS) in patients with acute chest pain
by: Dragojević Ilija, et al.
Published: (2014-01-01) -
Ischemia modified albumin as laboratory marker of acute
by: Goran Miličević, et al.
Published: (2009-02-01) -
Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?
by: Sahin A, et al.
Published: (2018-03-01) -
A synergistic role of ischemia modified albumin and high-sensitivity troponin T in the early diagnosis of acute coronary syndrome
by: Mihir D Mehta, et al.
Published: (2015-01-01) -
Serum Ischemia-Modified Albumin Concentration and Ischemia-Modified Albumin/Albumin Ratio in Hyperemesis Gravidarum
by: Fatma Beyazıt, et al.
Published: (2018-12-01)